This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Walgreen Is Terrific, After That CVS

NEW YORK ( F.A.S.T. Graphs) -- Anyone vaguely familiar with TheStreet.com knows co-founder Jim Cramer.

While browsing other sites, I happened upon an update of Jim Cramer's show "Mad Money" by SeekingAlpha.com editor Miriam Metzinger. The article I'm specifically referencing can be found here, but the show is also on TheStreet here. You can see the video here.

Here's the quote from the original article that caught my attention: "CVS is terrific. After that I like Walgreen."

While I would certainly agree with Cramer in that both are great companies, perhaps you noticed my slight turn of the phrase within the headline. I could describe my reasoning, but I believe that a picture tells a thousand words.

Thus, allow us to view Walgreen (WAG) and CVS (CVS - Get Report) through the lens of the F.A.S.T. Graphs fundamental analyzer software tool:

In viewing the business results of WAG, one notices a nearly perfect record of increased earnings. Indeed, over the last 15 years Walgreen has been able to grow earnings by almost 13% a year. Aside from a hiccup in 2012, the business has been the essence of consistency. If we move to the Fundamental Underlying Numbers (FUN) Graphs, a quick check of revenue (sale) and common equity, otherwise known as book value, tells a parallel story.

Sales grew from about $15 billion just before the turn of the millennium to $71 billion in the last year, or at an annualized rate of 11.65%. Likewise, book value grew from just under $3 billion to just over $18 billion, or at a compound annual rate of 14.18% over the last decade and a half. Obviously, the future performance is paramount to consider in viewing Walgreen as a potential investment. But if management can demonstrate analogous results in the future then it appears to be a sensible place for further due diligence.

Allow us to now look at CVS with the same characteristics in mind.

Here we see effectively the same graph that was demonstrated by Walgreen. In fact, if one were to quickly glance at both charts I would imagine they could easily be confused -- each had a small earnings misstep of late but has otherwise exhibited model consistency. Moreover, the 12.7% annual operating earnings growth rate for CVS is effectively the same number as Walgreen's 12.8% mark.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG
CVS $102.26 -0.92%
WAG $81.65 2.05%
AAPL $124.25 -0.14%
FB $81.66 -0.67%
GOOG $542.56 -0.99%

Markets

DOW 17,698.18 -77.94 -0.44%
S&P 500 2,059.69 -8.20 -0.40%
NASDAQ 4,880.2280 -20.6570 -0.42%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs